Protein Biomarkers and Host RNA Expression Profiles in Congenital Cytomegalovirus Infection
Recruiting
Observational Study
Congenital Cytomegalovirus
Cytomegalovirus Infections
Neonatal Infection
Sensorineural Hearing Loss
Viral Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 Days – 28 Days
- Sex
- Any
- Study type
- Observational
- Participants needed
- 630 (estimated)
- Sponsor
- Rigshospitalet, Denmark · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study seeks to identify and test host protein biomarkers and RNA expression profiles in dried blood spot samples as novel diagnostic markers of congenital cytomegalovirus sequelae and to improve the understanding of the pathogenesis of the disease.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Children born between 1 January 2010 and 31 December 2025 with an available neonatal dried blood spot sample collected through the Danish National Newborn Screening Program.
2. Cases: children with verified congenital CMV infection, defined as a positive CMV PCR result on neo…
Contacts